Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.858
-0.026 (-2.99%)
Jan 7, 2025, 3:15 PM EST - Market open
Omega Therapeutics Stock Forecast
OMGA's stock price has decreased by -79.01% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Omega Therapeutics stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 12. The average target predicts an increase of 972.26% from the current stock price of 0.86.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for OMGA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $4 | Buy | Maintains | $9 → $4 | +366.20% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +1,298.60% | Aug 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,298.60% | Aug 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +599.30% | Aug 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $12 | Buy | Initiates | $12 | +1,298.60% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
8.76M
from 3.09M
Increased by 183.26%
Revenue Next Year
5.11M
from 8.76M
Decreased by -41.75%
EPS This Year
-1.21
from -1.80
EPS Next Year
-0.66
from -1.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.9M | 6.9M | 6.9M | |||
| Avg | 8.8M | 5.1M | 6.7M | |||
| Low | 7.5M | 2.0M | 6.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 221.0% | -20.7% | 36.1% | |||
| Avg | 183.3% | -41.8% | 32.2% | |||
| Low | 141.0% | -77.6% | 27.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.19 | -0.39 | -0.36 | |||
| Avg | -1.21 | -0.66 | -0.40 | |||
| Low | -1.21 | -1.16 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.